Autonomix Medical, Inc. Common Stock Total Liabilities

Latest as of June 2026: $818.00K USD

Autonomix Medical, Inc. Common Stock total liabilities. Based on the latest financial reports, Autonomix Medical, Inc. Common Stock (AMIX) has total liabilities worth $818.00K USD as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See AMIX current assets to equity ratio to evaluate short-term liquidity relative to the company's equity base.

Total Liabilities of Autonomix Medical, Inc. Common Stock (2022–2026)

Total liabilities of Autonomix Medical, Inc. Common Stock from 2022 to 2026. This chart illustrates how Autonomix Medical, Inc. Common Stock's total liabilities have evolved over time, based on quarterly financial data.

Autonomix Medical, Inc. Common Stock Competitors by Total Liabilities

The table below lists competitors of Autonomix Medical, Inc. Common Stock ranked by their total liabilities.

Company Country Total Liabilities
OFAL
NASDAQ:OFAL
USA $8.89 Million
SRx Health Solutions Inc.
NYSE MKT:SRXH
USA $8.00 Million
Montanaro UK Smaller Companies Investment Trust PLC
LSE:MTU
UK GBX11.48 Million
Haoxin Holdings Limited Class A Ordinary Shares
NASDAQ:HXHX
USA $22.65 Million
KARELIAN DIA.R. EO-00025
F:KJY1
Germany €2.15 Million
Morarjee Textiles Limited
NSE:MORARJEE
India Rs9.20 Billion
Univa Foods Limited
NSE:UNIVAFOODS
India Rs8.85 Million
Sienna Resources Inc
V:SIE
Canada CA$137.82K

Liability Composition Analysis (2022–2026)

This chart breaks down Autonomix Medical, Inc. Common Stock's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Autonomix Medical, Inc. Common Stock total assets.

Liquidity & Leverage Metrics

Autonomix Medical, Inc. Common Stock Total Liabilities Ratios Explained

Autonomix Medical, Inc. Common Stock total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 4.85 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.26 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.21 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Autonomix Medical, Inc. Common Stock's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Autonomix Medical, Inc. Common Stock (2022–2026)

The table below shows the annual total liabilities of Autonomix Medical, Inc. Common Stock from 2022 to 2026.

Year Total Liabilities Change
2026-03-31 $1.71 Million -0.12%
2025-03-31 $1.71 Million -4.05%
2024-03-31 $1.78 Million +704.98%
2023-03-31 $221.00K +137.02%
2022-03-31 $93.24K --

About Autonomix Medical, Inc. Common Stock

NASDAQ:AMIX USA Medical Devices
Market Cap
$1.48 Million
Market Cap Rank
#30332 Global
#6183 in USA
Share Price
$1.52
Change (1 day)
+0.00%
52-Week Range
$0.28 - $19.50
All Time High
$118.80
About

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system. The company's technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system. It develops technology for patients with … Read more